|
Supplementary Financial Data
Quarterly Data (Unaudited)
| Year ended April 3, 2004 | First Quarter |
Second Quarter | Third Quarter |
Fourth Quarter |
|||||
| (In thousands, except per share amounts) | |||||||||
| Net revenues | $313,287 | $315,547 | $365,632 | $403,380 | |||||
| Gross margin | 188,188 | 192,650 | 225,958 | 261,082 | |||||
| Net income | 46,241 | (1) | 56,410 | 69,449 | (2) | 130,889 | (3) | ||
| Net income per share: | |||||||||
| Basic | $ 0.14 |
$0.17 |
$0.20 |
$0.38 |
|||||
| Diluted | $0.13 |
$0.16 |
$0.19 |
$0.36 |
|||||
| Shares used in per share calculations: | |||||||||
| Basic | 339,761 | 341,295 | 342,861 | 346,477 | |||||
| Diluted | 351,780 | 353,366 | 356,226 | 361,035 | |||||
| (1) | Net income includes litigation settlement and contingency of $6,400. |
| (2) | Net income includes impairment loss on excess facilities of $3,376. |
| (3) | Net income includes a $34,418 reduction in taxes associated with an IRS tax settlement and a write-off of acquired in-process research and development of $6,969 related to the acquisition of Triscend. |
| Year ended March 29, 2003 | First Quarter |
Second Quarter | Third Quarter |
Fourth Quarter |
|||||
| (In thousands, except per share amounts) | |||||||||
| Net revenues | $289,853 | $277,871 | $282,739 | $305,514 | |||||
| Gross margin | 169,517 | 164,130 | 165,616 | 183,163 | |||||
| Net income (loss) | 41,006 | 38,720 | (3,430 | )(1) | 49,409 | (2) | |||
| Net income (loss) per share: | |||||||||
| Basic | $0.12 |
$0.11 |
$(0.01 |
) | $0.15 |
||||
| Diluted | $0.12 |
$0.11 |
$(0.01 |
) | $0.14 |
||||
| Shares used in per share calculations: | |||||||||
| Basic | 336,518 | 337,481 | 337,242 | 337,920 | |||||
| Diluted | 351,858 | 346,902 | 337,242 | 348,410 | |||||
| (1) | Net income (loss) includes impairment loss on excess facilities and equipment of $54,691 and impairment loss on investments of $8,254. |
| (2) | Net income (loss) includes impairment loss on investments of $2,171. |